Exane Derivatives’s Avery Dennison AVY Stock Holding History

Exane Derivatives’s Portfolio AVY Stock Details AVY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-287	Closed	-$49.9K	–	791
2022 Q1	$49.9K	Buy	+287	New	+$53.4K	0.01%	570
2021 Q1	–	Sell	-8	Closed	-$1.24K	–	912
2020 Q4	$1.24K	Hold	8	–	–	﹤0.01%	662
2020 Q3	$1.02K	Hold	8	–	–	﹤0.01%	615
2020 Q2	$913	Hold	8	–	–	﹤0.01%	556
2020 Q1	$815	Hold	8	–	–	﹤0.01%	553
2019 Q4	$1.05K	Hold	8	–	–	﹤0.01%	542
2019 Q3	$908	Hold	8	–	–	﹤0.01%	544
2019 Q2	$925	Buy	+8	New	+$875	﹤0.01%	561
2019 Q1	–	Sell	-8	Closed	-$718	–	662
2018 Q4	$718	Hold	8	–	–	﹤0.01%	585
2018 Q3	$870	Hold	8	–	–	﹤0.01%	551
2018 Q2	$818	Hold	8	–	–	﹤0.01%	541
2018 Q1	$832	Sell	8 -29	-78%	-$3.36K	﹤0.01%	485
2017 Q4	$4.25K	Sell	37 -18,673	-100%	-$2.02M	﹤0.01%	433
2017 Q3	$1.84M	Buy	18,710 +18,707	+623,567%	+$1.76M	0.34%	51
2017 Q2	$265	Buy	3 +2	+200%	+$167	﹤0.01%	525
2017 Q1	$81	Hold	1	–	–	﹤0.01%	499
2016 Q4	$70	Hold	1	–	–	﹤0.01%	562
2016 Q3	$78	Sell	1 -162,091	-100%	-$12.4M	﹤0.01%	547
2016 Q2	$12.1M	Buy	+162,092	New	+$12M	2%	15
2015 Q3	–	Sell	-377,756	Closed	-$23M	–	537
2015 Q2	$23M	Buy	+377,756	New	+$22M	2.48%	13

Other funds holding AVY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Exane Derivatives's AVY Position: Q2 2022 in Review

Exane Derivatives sold out of Avery Dennison (AVY) in Q2 2022, closing a stake of 287 shares — an estimated $49.9K sold.

Exane Derivatives first reported a position in AVY in Q2 2015 and held it in 20 quarters. The position peaked at $23M in Q2 2015. 658 funds tracked by Wall St. Rank hold AVY as of Q2 2022.

Exane Derivatives reported no remaining Avery Dennison position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 287 Avery Dennison shares in Q2 2022, an estimated $49.9K.
Exane Derivatives first reported a position in Avery Dennison in Q2 2015 and held it in 20 quarters.
Exane Derivatives's Avery Dennison position peaked at $23M in Q2 2015.
658 funds tracked by Wall St. Rank held Avery Dennison as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.